Patents by Inventor Mi Ha Ju

Mi Ha Ju has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer-specific trans-splicing ribozymes and use thereof
    Patent number: 11078487
    Abstract: A cancer-specific trans-splicing ribozyme and a use thereof are disclosed. The trans-splicing ribozyme does not act on normal tissue, but is specifically expressed in cancer tissue. Therefore, it is very safe and has excellent expression efficiency at the post-transcription level, and thus can be effectively used in treatment of cancer.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: August 3, 2021
    Assignees: Rznomics Inc., Dong-A University Research Foundation for Industry Academy Cooperation, Industry-Academic Cooperation Foundation, Dankook University
    Inventors: Seong-Wook Lee, Chang Ho Lee, Seung Ryul I Han, Ji Hyun Kim, Eun Yi Cho, Jin Sook Jeong, Mi Ha Ju
  • CANCER-SPECIFIC TRANS-SPLICING RIBOZYMES AND USE THEREOF
    Publication number: 20200270612
    Abstract: A cancer-specific trans-splicing ribozyme and a use thereof are disclosed. The trans-splicing ribozyme does not act on normal tissue, but is specifically expressed in cancer tissue. Therefore, it is very safe and has excellent expression efficiency at the post-transcription level, and thus can be effectively used in treatment of cancer.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Applicants: Rznomics Inc., Dong-A University Research Foundation for Industry Academy Cooperation, Industry-Academic Cooperation Foundation, Dankook University
    Inventors: Seong-Wook Lee, Chang Ho Lee, Seung Ryul I Han, Ji Hyun Kim, Eun Yi Cho, Jin Sook Jeong, Mi Ha Ju